Quadrant Capital Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-177
Closed -$9.82K 1311
2026
Q1
$9.82K Buy
177
+2
+1% +$108 ﹤0.01% 2191
2025
Q4
$8.48K Hold
175
﹤0.01% 2247
2025
Q3
$5.36K Buy
+175
New +$4.02K ﹤0.01% 2310
2025
Q2
Sell
-175
Closed -$3.25K 1394
2025
Q1
$3.25K Sell
175
-110
-39% -$1.83K ﹤0.01% 2441
2024
Q4
$3.77K Sell
285
-52
-15% -$1.26K ﹤0.01% 2374
2024
Q3
$11.3K Hold
337
﹤0.01% 2106
2024
Q2
$8.45K Hold
337
﹤0.01% 2168
2024
Q1
$7.59K Hold
337
﹤0.01% 2197
2023
Q4
$7.22K Buy
337
+228
+209% +$3.93K ﹤0.01% 2181
2023
Q3
$1.96K Buy
109
+93
+581% +$1.77K ﹤0.01% 2398
2023
Q2
$326 Sell
16
-125
-89% -$2.53K ﹤0.01% 2621
2023
Q1
$3.07K Sell
141
-261
-65% -$6.34K ﹤0.01% 2341
2022
Q4
$12.5K Buy
402
+86
+27% +$2.43K ﹤0.01% 1848
2022
Q3
$8K Buy
316
+117
+59% +$2.74K ﹤0.01% 1949
2022
Q2
$4K Buy
199
+183
+1,144% +$4.05K ﹤0.01% 2011
2022
Q1
$0 Hold
16
﹤0.01% 2484
2021
Q4
$1K Hold
16
﹤0.01% 2237
2021
Q3
$0 Hold
16
﹤0.01% 2490
2021
Q2
$0 Hold
16
﹤0.01% 2399
2021
Q1
$0 Hold
16
﹤0.01% 2376
2020
Q4
$0 Hold
16
﹤0.01% 2286
2020
Q3
$0 Buy
16
+3
+23% +$54 ﹤0.01% 2154
2020
Q2
$0 Sell
13
-1,484
-99% -$27.1K ﹤0.01% 2208
2020
Q1
$21K Buy
+1,497
New +$22.7K ﹤0.01% 1248

Other funds holding ANAB

Quadrant Capital Group's ANAB Position: Q2 2026 in Review

Quadrant Capital Group sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 177 shares — an estimated $9.82K sold.

Quadrant Capital Group first reported a position in ANAB in Q1 2020 and held it in 24 quarters. The position peaked at $21K in Q1 2020. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Quadrant Capital Group reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 177 AnaptysBio shares in Q2 2026, an estimated $9.82K.
  • Quadrant Capital Group first reported a position in AnaptysBio in Q1 2020 and held it in 24 quarters.
  • Quadrant Capital Group's AnaptysBio position peaked at $21K in Q1 2020.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.